ClinicalTrials.Veeva

Menu

Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

K

Kansai Hepatobiliary Oncology Group

Status

Completed

Conditions

Intrahepatic Cholangiocarcinoma

Study type

Observational

Funder types

NETWORK

Identifiers

NCT01862276
UMIN000010416 (Registry Identifier)
KHBO1206

Details and patient eligibility

About

To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.

Full description

The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.

Enrollment

200 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cases of major hepatectomy due to intrahepatic cholangiocarcinoma

Exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems